Tuesday, December 29, 2015 6:09:20 PM
On December 4, 2015, Enzon Pharmaceuticals, Inc. (the “Company”) was advised by NASDAQ that an ex-dividend date of December 30, 2015 has been established for the $0.25 special cash dividend per share that was announced by the Company on December 3, 2015. As previously announced, the $0.25 special cash dividend per share is payable on December 29, 2015 to stockholders of record as of the close of business on December 14, 2015.
Recent ENZN News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:07:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:05:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:31:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2023 08:06:31 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM